The UK Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have opened a call for evidence to assess the impact of resources produced under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme.
The survey opened on 5 November 2026 and will remain open until 26 February 2027, according to the two organisations.
Who is being asked to respond
The agencies are seeking feedback from a broad range of stakeholders, including:
- developers and manufacturers of digital mental health technologies;
- healthcare professionals and researchers;
- policymakers and regulators;
- people with lived experience of mental health conditions, carers and members of the public.
Participation is encouraged whether respondents have engaged extensively, minimally or not at all with the existing resources.
What the evaluation covers
The survey forms part of the programme's Phase 1 evaluation. The MHRA and NICE said they want to understand how the resources have been received and used across the sector, and whether the materials have influenced users' knowledge, confidence, decision-making and professional practice.
The resources were developed to support the safe development, regulation, evaluation and adoption of digital mental health technologies, including mental health apps and other digital tools.
Findings will be used to determine whether the Phase 1 outputs have met their intended objectives and to inform the future direction of Phase 2 of the DMHT programme. The organisations said the feedback will help identify strengths, highlight areas for improvement and shape future work aimed at improving the safety and effectiveness of digital mental health technologies.
